DEVELOPMENT AND APPLICATION OF NOVEL COMPUTATIONAL METHODS AND STRATEGIES FOR THE CHARACTERISATION OF HUMAN DISEASES.
Our research focuses on developing computational methods to better understand human diseases. Main research lines:
- Ageing and Age-Related Diseases: Identifying expression patterns in neurological, cancer, and metabolic diseases to study ageing.
- Improving the understanding of molecular mechanisms in brain disorders: a) Generation of single-cell and spatial atlases to decipher sex differences in neurodegenerative diseases (Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis and multiple sclerosis); b) Identification of biological pathways in behavioural alteration pathologies (schizophrenia); c) Study of differential sex profiles in neuroinflammation associated with alcohol use disorders, through integrative multi-omics strategies.
- Finding novel biomarkers in cancer: a) Development and application of big-data analysis methods for the identification of novel diagnostic and progression biomarkers in cancer studies; b) Neurobiology of cancer: description of the role of the nervous system in oncological diseases and identification of possible clinical implications in oncology.
- Clinical targets and predictors in metabolic disorders: a) Detection of potential clinical targets in obesity, diabetes and MAFLD (metabolic associated fatty liver disease) through massive analysis of omics data; b) Clinical predictors based on high-throughput technologies and artificial intelligence methods.
PRESENTATION
GET TO KNOW US BETTER
-
CIPF Cluster Platform for Research in the Valencian Community
-
METAFUN Data Science and Gender
-
-
RESEARCH STAFF
THE PEOPLE WHO MAKE IT ALL POSSIBLE
Francisco García García
fgarcia@cipf.es
Cristina Galiana Roselló
cgaliana@cipf.es
Carla Perpiñá Clerigues
cperpina@cipf.es
Irene Soler Saez
isoler@cipf.es
Borja Gómez Cabañes
bgomezc@cipf.es
Fernando Gordillo González
fgordillo@cipf.es
Rubén Sánchez García
rsanchez@cipf.es
Rubén Grillo Risco
rgrillo@cipf.es
PUBLICATIONS
OUR SCIENTIFIC CONTRIBUTIONS
An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease.
NEUROBIOLOGY OF DISEASE 2024 Sep,  DOI:  10.1016/j.nbd.2024.106605,  Vol. 199,  pag. 106605-106605
MetaFun: unveiling sex-based differences in multiple transcriptomic studies through comprehensive functional meta-analysis.
Biology of Sex Differences 2024 Aug,  DOI:  10.1186/s13293-024-00640-0,  Vol. 15,  pag. 66-66
Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies.
Biology of Sex Differences 2022 Nov,  DOI:  10.1186/s13293-022-00477-5,  Vol. 13,  pag. 68-68
Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.
JOURNAL OF INVESTIGATIVE DERMATOLOGY  ,  DOI:  10.1016/j.jid.2024.09.005,  Vol. ,  pag. 
Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies.
METABOLISM-CLINICAL AND EXPERIMENTAL 2025 Jul,  DOI:  10.1016/j.metabol.2025.156241,  Vol. 168,  pag. 156241-156241